knowledge -WSS

knowledge

author：Wikipedia 2025-10-02 13:14:34 - browse：75

Alex Hogan/STAT

SAN FRANCISCO — It seemed like there was a point during last year’s J.P. Morgan Healthcare Conference when we all collectively realized, “Oh, 2023 is going to be another slog.” Indeed, a downturn has weighed on the biotech industry for nearly three years.

But this January, things feel different. Maybe it’s the abundance of sunlight that filled San Francisco this week. More likely, it’s the surge of deals that came in December. Whatever the reason, sentiment around Union Square in recent days was markedly more positive this year.

Most everyone I spoke to this week noticed the change in tenor. “I’m feeling a lot of good energy, honestly,” Mira Chaurushiya, senior partner at VC Westlake Village BioPartners, told me Tuesday. “It’s not only what happened the last few weeks of the year, but what people are projecting moving forward.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： Readout Newsletter: Cardior, Regeneron, Nuvation, Dyne and more

entertainment

WSS

Donor acceptance rates hint at racial, gender bias in heart transplants: study

There's no autism epidemic. It's an autism diagnosis epidemic

Cigna wins case to block Amy Bricker's move to CVS

Readout LOUD podcast: mifepristone case, GLP

Abortion pill case raises question: who can sue the FDA?

Will generative AI in health care meet the fate of IBM's Dr. Watson?

hotspot

knowledge

focus

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

ALS patient reclaims some autonomy thanks to wearable 'robot'

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Oprah kicked off a national conversation on obesity. Let's have it

BioMarin wins approval for gene therapy to treat hemophilia A

STAT Virtual Event: ASCO Recap, Live!

Jerome Adams on the need for new antivirals for Covid

Medical device trials still don't enroll enough women, study finds

As demand for Covid shots wanes, Moderna seeks its next success

The Readout: Lenmeldy, GLP

leisure time

There's no autism epidemic. It's an autism diagnosis epidemic

Oprah kicked off a national conversation on obesity. Let's have it

Roche subsidiary Foundation Medicine opens new headquarters

Covid vaccine financial winners and losers, from Pfizer to Novavax

Lilly's Alzheimer's drug donanemab backed by FDA advisers

Readout Newsletter: WuXi and Congress, Boundless Bio, etc.

hotspot

hotspot

entertainment

focus